Skip to menu Skip to content Skip to footer

2016

Journal Article

Single institution retrospective review of perioperative chemotherapy in adult and adolescent patients with operable osteosarcoma

Hansen, Aaron R., Hughes, Brett G., Paul, Sanjoy, Steadman, Peter, Sommerville, Scott, Dickinson, Ian C., Walpole, Euan T., Thomson, Damien B., Mar Fan, Helen G. and Joubert, Warren L. (2016). Single institution retrospective review of perioperative chemotherapy in adult and adolescent patients with operable osteosarcoma. Asia-Pacific Journal of Clinical Oncology, 12 (2), e222-e228. doi: 10.1111/ajco.12167

Single institution retrospective review of perioperative chemotherapy in adult and adolescent patients with operable osteosarcoma

2016

Journal Article

Alectinib in crizotinib-refractory alk-rearranged non-small-cell lung cancer: a phase II global study

Ou, Sai-Hong Ignatius, Ahn, Jin Seok, De Petris, Luigi, Govindan, Ramaswamy, Yang, James Chin-Hsin, Hughes, Brett, Lena, Herve, Moro-Sibilot, Denis, Bearz, Alessandra, Ramirez, Santiago Viteri, Mekhail, Tarek, Spira, Alexander, Bordogna, Walter, Balas, Bogdana, Morcos, Peter N., Monnet, Annabelle, Zeaiter, Ali and Kim, Dong-Wan (2016). Alectinib in crizotinib-refractory alk-rearranged non-small-cell lung cancer: a phase II global study. Journal of Clinical Oncology, 34 (7), 661-668. doi: 10.1200/JCO.2015.63.9443

Alectinib in crizotinib-refractory alk-rearranged non-small-cell lung cancer: a phase II global study

2016

Journal Article

Validation of an updated evidence-based protocol for proactive gastrostomy tube insertion in patients with head and neck cancer

Brown, T. E., Getliffe, V., Banks, M. D., Hughes, B. G. M., Lin, C. Y., Kenny L. M. and Bauer, J. (2016). Validation of an updated evidence-based protocol for proactive gastrostomy tube insertion in patients with head and neck cancer. European Journal of Clinical Nutrition, 70 (5), 1-8. doi: 10.1038/ejcn.2015.230

Validation of an updated evidence-based protocol for proactive gastrostomy tube insertion in patients with head and neck cancer

2015

Journal Article

A phase III randomized trial of adding topical nitroglycerin to first-line chemotherapy for advanced nonsmall-cell lung cancer: The Australasian lung cancer trials group NITRO trial

Davidson, A., Veillard, A. -S., Tognela, A., Chan, M. M. K., Hughes, B. G. M., Boyer, M., Briscoe, K., Begbie, S., Abdi, E., Crombie, C., Long, J., Boyce, A., Lewis, C. R., Varma, S., Broad, A., Muljadi, N., Chinchen, S., Espinoza, D., Coskinas, X., Pavlakis, N., Millward, M. and Stockler, M. R. (2015). A phase III randomized trial of adding topical nitroglycerin to first-line chemotherapy for advanced nonsmall-cell lung cancer: The Australasian lung cancer trials group NITRO trial. Annals of Oncology, 26 (11) mdv373, 2280-2286. doi: 10.1093/annonc/mdv373

A phase III randomized trial of adding topical nitroglycerin to first-line chemotherapy for advanced nonsmall-cell lung cancer: The Australasian lung cancer trials group NITRO trial

2015

Journal Article

Improving guideline sensitivity and specificity for the identification of proactive gastrostomy placement in patients with head and neck cancer

Brown, Teresa E., Crombie, Jane, Spurgin, Ann-Louise, Tripcony, Lee, Keller, Jacqui, Hughes, Brett G. M., Dickie, Graeme, Kenny, Lizbeth Moria and Hodge, Robert A. (2015). Improving guideline sensitivity and specificity for the identification of proactive gastrostomy placement in patients with head and neck cancer. Head and Neck, 38 Suppl 1, 1-9. doi: 10.1002/hed.24184

Improving guideline sensitivity and specificity for the identification of proactive gastrostomy placement in patients with head and neck cancer

2015

Journal Article

Patients' and doctors' preferences for adjuvant chemotherapy in resected non-small-cell lung cancer: what makes it worthwhile?

Blinman, Prunella, Hughes, Brett, Crombie, Catherine, Christmas, Tim, Hudson, Malcolm, Veillard, Anne-Sophie, Muljadi, Nick, Millward, Michael, Wright, Gavin, Flynn, Peter, Windsor, Morgan, Stockler, Martin and Mclachlan, Sue-Anne (2015). Patients' and doctors' preferences for adjuvant chemotherapy in resected non-small-cell lung cancer: what makes it worthwhile?. European Journal of Cancer, 51 (12) 9495, 1529-1537. doi: 10.1016/j.ejca.2015.05.022

Patients' and doctors' preferences for adjuvant chemotherapy in resected non-small-cell lung cancer: what makes it worthwhile?

2015

Journal Article

Swallowing outcomes and PEG dependence in head and neck cancer patients receiving definitive or adjuvant radiotherapy +/− chemotherapy with a proactive PEG: a prospective study with long term follow up

Crombie, Jane M., Ng, Stephanie, Spurgin, Ann-Louise, Ward, Elizabeth C., Brown, Teresa E. and Hughes, Brett G. M. (2015). Swallowing outcomes and PEG dependence in head and neck cancer patients receiving definitive or adjuvant radiotherapy +/− chemotherapy with a proactive PEG: a prospective study with long term follow up. Oral Oncology, 51 (6) 3212, 622-628. doi: 10.1016/j.oraloncology.2015.03.006

Swallowing outcomes and PEG dependence in head and neck cancer patients receiving definitive or adjuvant radiotherapy +/− chemotherapy with a proactive PEG: a prospective study with long term follow up

2015

Journal Article

Targeted therapy for non-small cell lung cancer: Current standards and the promise of the future

Chan, Bryan A. and Hughes, Brett G.M. (2015). Targeted therapy for non-small cell lung cancer: Current standards and the promise of the future. Translational Lung Cancer Research, 4 (1), 36-54. doi: 10.3978/j.issn.2218-6751.2014.05.01

Targeted therapy for non-small cell lung cancer: Current standards and the promise of the future

2015

Journal Article

An unusual recurrence of adenosquamous carcinoma of the lung

Pokharel, Khageshwor, Godbolt, David and Hughes, Brett G. M. (2015). An unusual recurrence of adenosquamous carcinoma of the lung. Cancer Treatment Communications, 4, 37-40. doi: 10.1016/j.ctrc.2015.03.006

An unusual recurrence of adenosquamous carcinoma of the lung

2014

Journal Article

First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer

Solomon, Benjamin J., Mok, Tony, Kim, Dong-Wan, Wu, Yi-Long, Nakagawa, Kazuhiko, Mekhail, Tarek, Felip, Enriqueta, Cappuzzo, Federico, Paolini, Jolanda, Usari, Tiziana, Iyer, Shrividya, Reisman, Arlene, Wilner, Keith D., Tursi, Jennifer, Blackhall, Fiona, Boyer, M., Ganju, V., Hughes, B., Pavlakis, N., Solomon, B., Varma, S., Berghmans, T., Canon, J-L, Demedts, I., Janssens, A., Louis, R., Pieters, T., Schallier, D., Surmont, V. ... Waqar, S. (2014). First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer. New England Journal of Medicine, 371 (23), 2167-2177. doi: 10.1056/NEJMoa1408440

First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer

2014

Journal Article

Phase II study of single-agent panitumumab in patients with incurable cutaneous squamous cell carcinoma

Foote, M. C., McGrath, M., Guminski, A., Hughes, B. G. M., Meakin, J., Thomson, D., Zarate, D., Simpson, F. and Porceddu, S. V. (2014). Phase II study of single-agent panitumumab in patients with incurable cutaneous squamous cell carcinoma. Annals of Oncology, 25 (10), 2047-2052. doi: 10.1093/annonc/mdu368

Phase II study of single-agent panitumumab in patients with incurable cutaneous squamous cell carcinoma

2014

Journal Article

Nutrition outcomes following implementation of validated swallowing and nutrition guidelines for patients with head and neck cancer

Brown, Teresa, Ross, Lynda, Jones, Lee, Hughes, Brett and Banks, Merrilyn (2014). Nutrition outcomes following implementation of validated swallowing and nutrition guidelines for patients with head and neck cancer. Supportive Care in Cancer, 22 (9), 2381-2391. doi: 10.1007/s00520-014-2180-9

Nutrition outcomes following implementation of validated swallowing and nutrition guidelines for patients with head and neck cancer

2014

Journal Article

Protocol for a randomized controlled trial of early prophylactic feeding via gastrostomy versus standard care in high risk patients with head and neck cancer

Brown, Teresa, Banks, Merrilyn, Hughes, Brett, Kenny, Lizbeth, Lin, Charles and Bauer, Judith (2014). Protocol for a randomized controlled trial of early prophylactic feeding via gastrostomy versus standard care in high risk patients with head and neck cancer. BMC Nursing, 13 (1) 17, 17.1-17.10. doi: 10.1186/1472-6955-13-17

Protocol for a randomized controlled trial of early prophylactic feeding via gastrostomy versus standard care in high risk patients with head and neck cancer

2014

Journal Article

The ENHANCES study-enhancing head and neck cancer patients' experiences of survivorship: study protocol for a randomized controlled trial

Turner, Jane, Yates, Patsy, Kenny, Lizbeth, Gordon, Louisa G., Burmeister, Bryan, Thomson, Damien, Hughes, Brett, McCarthy, Alexandra L., Perry, Chris, Chan, Raymond J., Fraser, Alana, Skerman, Helen, Batstone, Martin and Carswell, Kathryn (2014). The ENHANCES study-enhancing head and neck cancer patients' experiences of survivorship: study protocol for a randomized controlled trial. Trials, 15 (1) 191. doi: 10.1186/1745-6215-15-191

The ENHANCES study-enhancing head and neck cancer patients' experiences of survivorship: study protocol for a randomized controlled trial

2014

Journal Article

Myocardial infarction secondary to 5-fluorouracil: not an absolute contraindication to rechallenge?

Rateesh, Shruti, Luis, Sushil A., Luis, Chris R., Hughes, Brett and Nicolae, Mugur (2014). Myocardial infarction secondary to 5-fluorouracil: not an absolute contraindication to rechallenge?. International Journal of Cardiology, 172 (2), E331-E333. doi: 10.1016/j.ijcard.2013.12.274

Myocardial infarction secondary to 5-fluorouracil: not an absolute contraindication to rechallenge?

2014

Journal Article

Pertuzumab and erlotinib in patients with relapsed non-small cell lung cancer: a phase II study using 18F-fluorodeoxyglucose positron emission tomography/computed tomography imaging

Hughes, Brett, Mileshkin, Linda, Townley, Peter, Gitlitz, Barbara, Eaton, Keith, Mitchell, Paul, Hicks, Rodney, Wood, Katie, Amler, Lucas, Fine, Bernard M., Loecke, David and Pirzkall, Andrea (2014). Pertuzumab and erlotinib in patients with relapsed non-small cell lung cancer: a phase II study using 18F-fluorodeoxyglucose positron emission tomography/computed tomography imaging. Oncologist, 19 (2), 175-176. doi: 10.1634/theoncologist.2013-0026

Pertuzumab and erlotinib in patients with relapsed non-small cell lung cancer: a phase II study using 18F-fluorodeoxyglucose positron emission tomography/computed tomography imaging

2013

Journal Article

Validated swallowing and nutrition guidelines for patients with head and neck cancer: Identification of high-risk patients for proactive gastrostomy

Brown, Teresa E., Spurgin, Ann-Louise, Ross, Lynda, Tripcony, Lee, Keller, Jacqui, Hughes, Brett G. M., Hodge, Rob, Walker, Quenten, Banks, Merrilyn, Kenny, Lizbeth Moira and Crombie, Jane (2013). Validated swallowing and nutrition guidelines for patients with head and neck cancer: Identification of high-risk patients for proactive gastrostomy. Head and Neck, 35 (10), 1385-1391. doi: 10.1002/hed.23146

Validated swallowing and nutrition guidelines for patients with head and neck cancer: Identification of high-risk patients for proactive gastrostomy

2013

Journal Article

A phase II clinical trial of the vascular disrupting agent BNC105P as second line chemotherapy for advanced malignant pleural mesothelioma

Nowak, Anna K., Brown, Chris, Millward, Michael J., Creaney, Jenette, Byrne, Michael J., Hughes, Brett, Kremmidiotis, Gabriel, Bibby, David C., Leske, Annabell F., Mitchell, Paul L. R., Pavlakis, Nick, Boyer, Michael and Stockler, Martin R. (2013). A phase II clinical trial of the vascular disrupting agent BNC105P as second line chemotherapy for advanced malignant pleural mesothelioma. Lung Cancer, 81 (3), 422-427. doi: 10.1016/j.lungcan.2013.05.006

A phase II clinical trial of the vascular disrupting agent BNC105P as second line chemotherapy for advanced malignant pleural mesothelioma

2013

Journal Article

Comment on 'The efficacy and toxicity of gemcitabine, carboplatin and bevacizumab in metastatic breast cancer'

Kitchen, D., O'Brien, M., Hughes, B., Gill, I., Rumbles, S., Ellis, P. and Stebbing, J. (2013). Comment on 'The efficacy and toxicity of gemcitabine, carboplatin and bevacizumab in metastatic breast cancer'. British Journal of Cancer, 109 (2), 526-528. doi: 10.1038/bjc.2013.279

Comment on 'The efficacy and toxicity of gemcitabine, carboplatin and bevacizumab in metastatic breast cancer'

2013

Journal Article

Other novel molecular targets in non-small cell lung cancer: it's not all about EGFR

Cruikshank, Ross and Hughes, Brett (2013). Other novel molecular targets in non-small cell lung cancer: it's not all about EGFR. Cancer Forum, 37 (2), 170-174.

Other novel molecular targets in non-small cell lung cancer: it's not all about EGFR